DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click HERE
to register or log in.
In Vivo Imaging of Branched Chain Amino Acid Metabolism in Prostate Cancer
Annual rept. 15 Jul 2011-14 Jul 2012
STANFORD UNIV CA
Pagination or Media Count:
The primary objective of this research effort is the development of noninvasive imaging method to assess branchedchain amino acid metabolism known to be modified in prostate cancer PC to distinguish malignant from healthy tissue. The approach is to use MRSI of hyperpolarized 13C-ketoisocaproic acid KIC to interrogate its conversion to leucine as catalyzed by branched-chain aminotransferase BCAT. During this funding cycle, we 1. Developed a high-throughput assay for assessing in vitro BCAT activity. 2. Demonstrated BCAT activity in TRAMP mouse models was significantly lower than that found in human PC. 3. Searched for an animal model more closely mimicking human metabolism by assessing four prostate cancer cell lines PC-3, DU-145, LNCaP and LAPC-4. The PC-3 cells had the highest BCAT activity, although still appreciably lower than human PC. 4. Performed hyperpolarized in vivo MRS studies on PC-3 xenografts. Although the xenograph BCAT activity was 2.5 fold higher than cells alone approaching human levels, the tumors grew very poorly volumes 0.2 cc, as compared to the expected 1 cc and were inadequate to yield sufficient SNR for the in vivo MRS studies. 5. Initiated additional xenografts studies as well as investigation into other PC metabolic pathways.
APPROVED FOR PUBLIC RELEASE